|
|
|
26.03.26 - 10:54
|
Getinge publishes Annual Report for 2025 (PR Newswire)
|
|
|
GOTHENBURG, Sweden, March 26, 2026 /PRNewswire/ -- Today, Getinge publishes its Annual Report for 2025, including the Sustainability statement. The year was marked by geopolitical friction and significant cost impacts from tariffs and currency movements, while the company delivered strong......
|
|
|
26.03.26 - 10:01
|
Getinge publishes Annual Report for 2025 (Cision)
|
|
|
Today, Getinge publishes its Annual Report for 2025, including the Sustainability statement. The year was marked by geopolitical friction and significant cost impacts from tariffs and currency movements, while the company delivered strong underlying profitability, continued regulatory progress, and an ambitious innovation agenda.
Getinge's 2025 Annual Report summarizes the year's performance, both financially and in sustainability, and provides an overview of the company's strategy, targets, and governance. The medtech company's net sales in 2025 amounted to SEK 35 billion, with organic...
|
|
|
24.03.26 - 09:02
|
Getinge Advances ECLS Technology with Cardiohelp II – The Next Evolution in Extracorporeal Life Support (Cision)
|
|
|
Getinge today announced the receipt of CE mark for Cardiohelp II, the next evolution of its extracorporeal life support (ECLS) platform. Building on the legacy of Cardiohelp-i - widely recognized within acute care for shaping modern extracorporeal membrane oxygenation (ECMO) transport and extracorporeal life support practice - Cardiohelp II represents the next step forward in intelligent, connected and clinically advanced ECLS.
[image]
As a global leader in cardiopulmonary technologies, Getinge has played a defining role in the development and broader adoption of modern ECLS practice....
|
|
|
18.03.26 - 14:24
|
Getinge′s iCast[®] covered stent system expands U.S. offering with additional sizes (Cision)
|
|
|
Getinge has received U.S. FDA Premarket Approval (PMA) for additional sizes of its iCast covered stent system, expanding treatment options for patients with occlusive disease. The approval includes a new 10 mm diameter by 59 mm length, new 32 mm lengths, and new 12 mm large diameter options.
[image]
These newly approved sizes enable physicians to treat a broader range of vessel and lesion diameters and lengths, increasing procedural flexibility and expanding access to the iCast covered stent system for more patients across the U.S.
”We are excited to bring this important portfolio...
|
|
|
12.03.26 - 08:00
|
NOTICE OF ANNUAL GENERAL MEETING IN GETINGE AB (PUBL) (Cision)
|
|
|
The shareholders of Getinge AB (publ), corporate ID No. 556408-5032, (“Getinge”) are hereby invited to attend the Annual General Meeting (the “AGM”) on Tuesday, April 21, 2026 at 3.00 p.m. CEST, in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. Entrance registration starts at 2.00 p.m. CEST. A lighter snack will be served after the AGM. The Board of Directors of Getinge has decided that the shareholders shall be able to exercise their voting right at the AGM by postal voting in accordance with the regulations in Getinge's Articles of Association, as further described below.
RIGHT TO...
|
|
|
|
|
|
|
|
|
|
|
27.01.26 - 09:01
|
Getinge AB Q4 Profit Climbs (AFX)
|
|
|
STOCKHOLM (dpa-AFX) - Getinge AB (GETI-B.ST) released earnings for its fourth quarter that Increases, from the same period last yearThe company's bottom line came in at SEK868 million, or SEK3.19 ......
|
|
|
|
|
|
|
27.01.26 - 08:00
|
Getinge Q4 and Full-Year Report 2025: Organic growth and solid cash flow to end the year (Cision)
|
|
|
“We succeeded in growing organically, delivering a record-breaking fourth quarter and organic growth at the upper end of our forecast, 4.9% for the full year,” says Mattias Perjos, President & CEO at Getinge.
Higher demand for consumables for ECLS-therapy in the quarter and in Acute Care Therapies contributed to Getinge's performance. Sales were also strong in Transplant Care and ventilators. Surgical Workflows continued to strengthen its market-leading position in operating tables and enters 2026 with robust order bookings. In general, sales are more volatile between quarters for Life...
|
|
|
21.01.26 - 15:36
|
Planview Enters 2026 with New Leadership and Continued AI Innovation (Business Wire)
|
|
|
Company fueled by strong 2025 customer momentumAUSTIN, Texas--(BUSINESS WIRE)--Planview®, the leading platform for Strategic Portfolio Management (SPM) and Digital Product Development (DPD), today announced strong 2025 momentum, driven by significant customer growth, AI innovation, and industry recognition throughout the year. Additionally, Planview enters 2026 with new CEO Matt Zilli at the helm and an updated leadership team to accelerate its AI-first strategy.
New Logo and Customer Momentum in 2025
Key customer wins and expansions across Financial Services, Insurance, Healthcare, Technology, Retail, and more have driven Planview's continued profitable growth. In 2025, the company added 274 net new customers; notable customers who selected or expanded their footprint with Planview in 2025 included: Currys Group, DHL, DTCC, EDF Renewables, Farmacia Guadalajara, Fisher & Paykel Healthcare, FIS, Garrett Motion, General Mills, Getinge Sterilization, Global Payments, Harman Connected Services, HCSC, Huntin...
|
|
|
13.01.26 - 08:06
|
Getinge invites fund managers, analysts, and media to Year-End Report 2025 conference call (Cision)
|
|
|
Getinge will issue its Year-End Report 2025 on January 27, 2026, at 08.00 a.m. CET, followed by a conference call at 10.00 a.m. CET, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.
Fund managers, analysts and media are invited to participate in the conference call.
To participate via teleconference, please register via this link (https://events.inderes.com/getinge/q4-report-2025/dial-in). After registration, you will be provided with telephone numbers and a conference ID to access the conference. You can ask questions verbally via the telephone conference.
During the...
|
|
|
19.12.25 - 09:00
|
Getinge transforms sterile reprocessing with Automatiq - a full range of logistic automation modules (Cision)
|
|
|
Getinge is unveiling Automatiq, a new family of next generation automated solutions designed to help Central Sterile Supply Departments (CSSDs) achieve safer, more consistent and less labor-intensive sterile reprocessing. Automatiq seamlessly combines smart robotics, intelligent conveyor systems and advanced software to optimize sterile reprocessing and enhance workflow efficiency at every step.
[image]
CSSDs play a vital role in infection prevention and represent one of the most precise and physically demanding processes in the hospital. During traditional manual processes, CSSD...
|
|
|
18.12.25 - 09:01
|
Camilla Sylvest is proposed for Getinge AB′s Board of Directors (Cision)
|
|
|
The Nomination Committee of Getinge AB (publ) has decided to propose to the Annual General Meeting 2026 that the Meeting elects Camilla Sylvest as a new member of the Board of Directors. The Nomination Committee also informs that the current Board member Malin Persson, who has served since 2014, has announced that she will not be available for re-election in 2026.
Camilla Sylvest has more than 28 years of experience at Novo Nordisk A/S, most recently serving eight years as Executive Vice President, Commercial Strategy and Corporate Affairs, and as a member of the executive management team....
|
|
|
|
|
25.11.25 - 17:06
|
Getinge and SteriPro International Inc. announce strategic partnership for sterile processing optimization (Cision)
|
|
|
Today, Getinge and SteriPro International Inc. announced a new strategic partnership that reinforces safer workflows and a scalable model for the future of surgical services within Sterile Processing departments across North America.
[image]
The unique partnership brings together two complementary strengths: Getinge's proven leadership in sterile processing equipment, automation, and digital workflow solutions, and SteriPro's deep expertise in off-site reprocessing operations.
Together, Getinge and SteriPro look to raise quality, increase transparency, and steer meaningful cost...
|
|
|
20.11.25 - 09:01
|
Getinge introduces new version of Solsus 66 to meet CSSD efficiency needs (Cision)
|
|
|
Getinge introduces a new version of its trusted Solsus 66 Steam Sterilizer – originally launched in 2020 – designed to meet the evolving needs of Central Sterile Supply Departments (CSSDs).
[image]
Sterile reprocessing is essential to safe and efficient healthcare. Hospitals face increasing pressure to deliver high-quality care while managing costs and space. Getinge´s Solsus 66 helps CSSDs meet these demands. Built on robust technology with over 20 years of heritage, it has become a reliable partner in sterile reprocessing. The new version retains its proven performance while introducing...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
